Not logged in.png)
Share.png)
SaveShare Save Share Save FURTHER: A global study to evaluate furmonertinib in patients with EGFR mutant NSCLC including uncommon EGFR mutations
Le, Xiuning; Spira, Alexander; Gadgeel, Shirish; Yu, Yan; Zhao, Yanqiu; Cheng, Ying; Riess, Jonathan; Juan-Vidal, Oscar; Gao, Bo; Yoh, Kiyotaka; Forster, Martin; Kitazono, Satoru; Hayashi, Hidetoshi; Planchard, David; Jiang, Yong; Huang, Jack; Baio, Nichole; Kowanetz, Marcin; Wang, Shirley; Leung, William; Hsu, Jerry Y.; Wang, Jie Share Save Safety and efficacy of JSKN003 in patients with advanced/metastatic solid tumors: A first-in-human, dose-escalation, multicenter, open-label, phase I studyBeecroft, Claire; Gao, Bo; Park, John; Wilkinson, Kate; Zhang, Karl; Yan, Xiangyun; Lv, Yuan Share Save Plasma pre-treatment T790M relative allelic frequency in patients with advanced EGFR-mutated non-small cell lung cancer predicts treatment response to subsequent-line osimertinibDing, Pei N.; Roberts, Tara L.; Chua, Wei; Becker, Therese M.; Caixeiro, Nicole; de Souza, Paul; Gao, Bo; Lee, Chee K.; Itchins, Malinda; Westman, Helen; Clarke, Stephen; Blinman, Prunella; Kao, Steven; John, Tom; Leal, Jose L.; Bray, Victoria J. Share Save Share Save Exploring the germ-line contribution to exceptional response to PD-1/PD-L1 inhibition in patients with metastatic non-small-cell lung cancer by whole genome sequencingBarnet, Megan B.; Jackson, Katherine J.; Gao, Bo; Nagrial, Adnan M.; Boyer, Michael J.; Cooper, Wendy A.; Hui, Rina; Linton, Anthony; Tattersall, Martin H.; Gibson, Greg; Cebon, Jonathan; Long, Georgina V.; Menzies, Alexander M.; Scolyer, Richard A.; Lacaze, Paul; Brink, Robert; Peters, Timothy; Cowley, Mark; Gayevskiy, Velimir; Thomas, David M.; Pinese, Mark; Blinman, Prunella; Kao, Steven; Goodnow, Christopher C. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
